<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03377946</url>
  </required_header>
  <id_info>
    <org_study_id>CHPF2017019</org_study_id>
    <nct_id>NCT03377946</nct_id>
  </id_info>
  <brief_title>Effect of Probiotics on Pre-diabetes and Diabetes in China</brief_title>
  <official_title>Effect of Probiotics on Pre-diabetes and Diabetes in China-the Role of Gut Microbiota Composition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed at verifying the effects of probiotics (KAWAI:dead S.thermophilus) on
      glucos management among T2DM and pre-diabetes Chinese adult. Additionally, the investigators
      intend to verify the effects of probiotics on modifying the structure and function of gut
      microbiome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: double-blind, randomized controlled trial. Number of participants: 160 patients with
      pre-diabetes and 60 diabetes. Intervention time: 3months. Data and Specimen collection time:
      at baseline and after the intervention.

      Observation index

        1. Physical measurement: gender, age, weight, BMI, waist circumference, hip circumference,
           waist-to-hip ratio, systolic pressure, diastolic blood pressure.

        2. Lifestyle questionnaire: diet, drinking, exercise, sleep and other habits.

        3. Blood test: blood glucose, OGTT, blood lipid, TNF-a, il-6, il-10, LPS, glp-1, gut
           microbiome metabolism products, T2DM related methylation.

      4. Gut microbiome detection: gut microbiome 16Sr DNA sequencing, gut microbiome
      bioinformatics analysis
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 21, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of blood glucose and insulin sensitivity</measure>
    <time_frame>3~5 years</time_frame>
    <description>blood glucose of fasting and 2 hours after OGTT，fasting insulin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of gut microbiota composition</measure>
    <time_frame>3~5 years</time_frame>
    <description>Feces gut microbiome 16Sr DNA sequencing, gut microbiome bioinformatics analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of blood inflammatory markers</measure>
    <time_frame>3~5 years</time_frame>
    <description>blood TNF-a, Il-6, Il-10, LPS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite changes in diabetes risk factors</measure>
    <time_frame>3~5 years</time_frame>
    <description>blood pressure, triglyceride,Cholesterol,LDL,HDL, weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite changes of weight, waist circumference and BMI</measure>
    <time_frame>3~5 years</time_frame>
    <description>weight, waist circumference,BMI,body fat</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes of Intestinal endocrine function</measure>
    <time_frame>3~5 years</time_frame>
    <description>Blood GLP-1</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>probiotics on type 2 diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>take probiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>probiotics on pre-diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>take probiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo on type 2 diabetes</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>take placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo on pre-diabetes</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>take placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>probiotics</intervention_name>
    <description>the probiotics group was taking probiotics 4 packets a day</description>
    <arm_group_label>probiotics on type 2 diabetes</arm_group_label>
    <arm_group_label>probiotics on pre-diabetes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>the placebo group was taking placebo 4 packets a day</description>
    <arm_group_label>placebo on type 2 diabetes</arm_group_label>
    <arm_group_label>placebo on pre-diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Meet Diabetes/pre-diabetes diagnostic criteria

          2. BMI 18-35kg/m2

        Exclusion Criteria:

          1. Patients with diabetes or hyperlipidemia, and need regular use of drugs.

          2. Secondary obesity or diabetes

          3. Digestive, tumor, heart, lung, kidney, rheumatic immunity and other systemic serious
             diseases

          4. Pregnant women, women ready for pregnancy, and nursing mothers

          5. Take antibiotics or bacterial agents within 1 month

          6. Diarrhea or abscess in 1 month or blood or other abnormal feces

          7. Diabetics have a history of more than 2 years

          8. The OGTT experiment of diabetic patients FG≥9mmol/L or 2h≥14mmol/L
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiang Zeng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fei Wang, MD</last_name>
    <phone>+86-10-68295950</phone>
    <email>wangfei301hmi@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>health management center,Southwest hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ya lan zhang, MD</last_name>
      <phone>13594348611</phone>
      <email>281072454@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>xiao lan zhao, MD</last_name>
      <phone>13608303976</phone>
      <email>zhaoxiaolan65@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2017</study_first_submitted>
  <study_first_submitted_qc>December 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2017</study_first_posted>
  <last_update_submitted>December 16, 2017</last_update_submitted>
  <last_update_submitted_qc>December 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Qiang Zeng</investigator_full_name>
    <investigator_title>Director of Health Management Institue</investigator_title>
  </responsible_party>
  <keyword>pre-diabetes,diabetes,probiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

